Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Okay thanks. Infuriating, our system has some serious flaws. Let’s hope and pray this get worked out not only for amarin and us investors but the patients that need this drug
No I agree But why wouldn’t Hikma and dr reedy not want to settle based off of what you are saying. Sounds to me Teva will dominate the market so makes no sense for them to not settle at this point.
Saying that why wouldn’t Hikma and dr reedy settle. Makes no sense especially if Teva will most likely rule the US market
Okay thanks so you think Europe and row only worth $4 billion in a BO. Not questioning you but seems low when have been hearing Europe and row worth 50% or more of us market before this generic deal
going off a lot of posters on this board and them talking about Europe and ROW. Again if I am
Wrong with this thinking then more then willing to listen but hearing anywhere from $6 billion to maybe up to $10 billion for Europe in a buyout
No I originally had over 50000 shares and have sold 14000 shares to get most of my money out
I am holding presently and am very much considering adding. I have close to 36000 shares average price around $2.
From all I am reading Europe and ROW worth anywhere between $15-25 a share so that puts it in perspective for me with stock at $5.
I will also say this, I held thru anchor debacle and company in much better position today then back then. I think we make it out of this and will be okay. How this transpires is anyones guess though
Also is the company even aware of this???
Question then and sorry if already asked as too many posts to go thru
If the PTO corrects this will that be admissible in the appeal?
Don’t think they accept $8 to $10 a share. Europe alone worth more than that. Let the dust clear and weigh options and I am not saying months from now but don’t rush to a decision at this point. Also start working on a way to correct this mess either by working on a settlement or doing what can be done to get the decision reversed in an appeal
JL what do you see as a way to get out of this mess by amarin as it looks like an appeal will take along time and may not be a win?
Are you in the sell Europe rights and be done or appeal and get it overturned?
JL how long would a reversal take?
Remember it is 1:15 there time so could still come today
If a BO what’s your price target
Larrybirdlegwnd thinks $100 plus do you agree
Although he is doubtful it would happen in this market
But you will care when this is all over so I would keep an eye out as the decision should be coming soon
So did I and also bought some apple stock
A lot of good stocks at discounted prices out there take advantage of it if you can
I keep on hearing Qtr 2 and that is when the fireworks happen. I have a crazy suspicion that will be the case. Just need to have some more patience. Only 9 years and counting for me but I have been very rewarded so far so can’t complain
Read pst 246532
They still own 34 million shares get a grip that is a ton of shares
Amen to that and to keeping JL on the board. Any long term investor will consider JL one of the most important contributors to this board, if not the most important (for me he is). JL is alittle uneasy presently but I guarantee you after the patent trial passes and amarin wins his insight for the future will be most valuable.
JL I know you like assymetical bets and this may be one
We have the patent case that highly favors amarin winning and the Europe indication that is worth more then the share price today
You know what your doing good luck
From my understanding the patent trial decision has no effect on Europe and why I am okay holding because Europe should be worth a minimum of $20 a share
I think $72 gets it done BUT long term I still think it is way low based on future opportunities. I for one am willing to take the risk but understand the ones who are not. If a deal does happen I would live to see future payouts based on milestones such as sales, Alzheimer’s etc.
I think you guys have short term views and IMO $42 is crazy low. I think $30 plus for Europe alone is reasonable from all I have been reading. Add $42 more for US and that may get things going but in the scheme of things that may be cheap long term. Yes I understand the risk BUT I also think of the opportunities in the future and they are huge.
I will in a heart beat if it means much higher prices in 2023 and then 2024 etc. you must be 75 and want your $ now
Small world my daughters went to st bens and Christ the king and are presently at Amhest high school. Love the school
I am a golfer and play every month typically except Jan and feb
Probably will be on the course this Friday
We don’t nearly get the snow we used to
Ps Louieblouie I live in Snyder and grew up in Williamsville
I live in buffalo don’t get same stations
Maybe 1 and not heavily watched station
Also for what it is worth at a party yesterday talking to a pediatrician and he mentions for me to look at a stock by the symbol of AMRN
I was blown away and I think he was that I have been invested since 2011
Well if the panel votes no this stock is getting crushed tomorrow correct ???
JL do you really think we could get a no vote?
Agree 100% man he is sharp and super poised
So would we have any way to get the label approval? I am just thinking worst case scenario
Question for the board if the adcom goes south like 2013( I believe it won’t and we will get a very broad label) obviously the stock will take a hit. My thought would be amarin takes the fda to court and wins and eventually gets the expanded label.
Do you agree with this thinking???
Won’t the stock be trading Friday November 15th?
I would expect good as I think his initial post would have had a different tone if bad
JMO
Ask bio billionaire if he is willing to share
Again I don’t think this is insider information if she responded to you BB but up to you
can’t see how this is insider information so don’t think there is any reason to not share
How can anyone in there right mind not see him for who he is. Would be a joke if the fda gave him more credibility then all these doctors and organizations combined. I can’t see it happening
JL I believe is spot on, this adcom is about label expansion and how wide a label
I received a reply from Elizabeth stating that although too early to say who will be there representing Amarin that Dr Bhatt wants to be there and the company expects him to be there.
IMO he will be there
A question for the board is I think our biggest fear is fda either denies the Reduce it label or issues a crl. If this happens do you all agree amarin will take this to the courts and win. This will somewhat delay things but in the end we get what we need which is approval.
Do you all agree with this statement????
I ask this question because if you are long the stock and have a five plus year time horizon we will get where we want to but may not in the way we hope to